Technology
A Healthier Life is Everyone's Wish.
Technical excellence
Adhesion occurs in all patients and can lead to death in severe cases.
Adhesion is the most common and dangerous side effect. We paid attention to anti-adhesion.
- Non-toxic No toxicity due to crosslinking agent using electron beam crosslinking technology
- Property control Decomposition period and shape (film, fabric, gel, etc.) can be adjusted
- Safety As a synthetic chemical material, it has high material stability and no genetic problems compared to biomaterials.
Technology development
Conduct clinical trials
Thyroid Clinical Trial
- Deep body wound epithelial cloning (adhesion prevention agent) is a grade 3 medical device and must be approved by K-FDA.
- Toxicity evaluation was conducted and passed at the Korea Industrial Technology Laboratory, and clinical trials were conducted at Pusan National University Hospital, National Cancer Center, Inje University Paik Hospital, and Nuclear Energy Hospital.
Head and neck clinical trial (scar relief effect)
- PEO-guard's second adaptation
- Clinically approved as the world’s first scar relief anti-adhesion agent applicable to the face
- Clinical trial conducted at Konyang University Hospital Near death in 2021
